
-
Alarm in Germany as 'dangerous' Maddie suspect set to walk
-
Italian fashion icon Giorgio Armani dead at 91
-
Pro-Palestinian protests rock Spain's Vuelta cycling race
-
Tourists and locals united in grief after Lisbon funicular crash
-
Comedy writer at centre of UK free-speech row in court on harassment charge
-
Europe leaders call Trump after Ukraine security guarantees summit
-
French museum hit by 9.5 mn euro porcelain heist
-
Berlusconi media group takes control of German broadcaster
-
European court faults France over sexual consent rules
-
Rain adds to misery of Afghan quake survivors
-
Rubio eyes tough-security ally in Ecuador
-
Afghanistan quake deadliest in decades, killing over 2,200
-
Coffee and cash: how Hamas pays its civil servants in secret
-
Stock markets mixed with eyes on US jobs data
-
China's Xi holds talks with North Korea's Kim in Beijing
-
Seniors back to work as ageing Germany battles pension burden
-
Spence on brink of history as first Muslim England player
-
Portugal holds day of mourning as crash toll rises to 17 dead
-
Taiwan star Shu Qi channels her childhood trauma into directorial debut
-
France's Ozon under the gun with big screen take on Camus classic
-
Zelensky meets European leaders on Ukraine security guarantees
-
Kolisi returns but won't captain Springboks against All Blacks
-
French women's boxing team barred from world champs over late gender test results
-
Asia markets mixed as Chinese stocks lose steam
-
'Biggest' Women's Asian Cup can help drive change, says top official
-
Searchers retrieve bodies as Afghan quake toll expected to rise
-
China's Xi at centre of world stage after days of high-level hobnobbing
-
Australia's Schmidt warns of 'super tough' Argentina test
-
Daniel Craig leads Hollywood stars to Toronto for 50th film fest
-
Trump admin asks Supreme Court for 'expedited' ruling on tariffs
-
Digital loan sharks prey on inflation-hit Nigerians
-
Climate change made heat behind deadly Iberian fires 40 times more likely: study
-
Campaign event for Argentina's Milei ends with skirmishes
-
Open mic caught Xi, Putin discussing immortality
-
Olympic champ Kennedy, Gout Gout headline Australia worlds squad
-
Skipper Wilson back as Wallabies face Argentina threat
-
Sinner powers into US Open semis, Anisimova gains Swiatek revenge
-
'Blood Moon' to rise during total lunar eclipse Sunday night
-
Sinner tames Musetti to march into US Open semi-finals
-
Gattuso begins Italy salvage operation with World Cup on the line
-
Sabalenka in Pegula US Open rematch as Osaka faces Anisimova
-
Immigration opposition fuels English national flag frenzy
-
Asia markets tick up after Wall Street rebound
-
Zelensky to meet European leaders after Putin vows to fight on
-
'Pink and green' protests call for a reset in Indonesia
-
Peruvian ex-presidents face courts in separate corruption trials
-
Wimbledon rewatch inspires Anisimova to US Open revenge
-
Ecuador eyes US security accords during Rubio's visit
-
Kyrgios predicts easy win over Sabalenka in 'Battle of the Sexes'
-
Osaka downs Muchova to reach US Open semi-final

Dogs die as South Africa snake antivenom shortage bites
Zarza, a much-loved Staffordshire terrier, ended up at a South African animal hospital with a bite from a Mozambique spitting cobra on her snout.
The snake's powerful venom can stop the breathing muscles from working, but normally the bites are treatable with an antidote.
The problem, say South African veterinarians, is that they currently have virtually no vials of the antiserum left.
"We've been out of antivenom for quite some months now," said Dean de Kock, a vet at the Valley Farm Animal Hospital in Pretoria, where Zarza was treated but eventually died.
Vets and snake experts say the shortage started getting serious towards the end of last year -- though the authorities are denying there is a problem.
"Snakebite antivenom is available in the country," the National Health Laboratory Service (NHLS), a government body in charge of antidote production, told AFP.
Experts in the field disagree.
- A 'countrywide shortage' -
In April, a group of snakebite treatment specialists pleaded with the health minister over what they described as "a major health risk".
While the supply problems may be easing in some quarters, vets say they are still struggling.
Hospitals treating humans get priority when any new doses come available, said Johan Marais, a herpetologist -- specialist in reptiles and amphibians -- who heads the African Snakebite Institute.
"At the moment, if you're a veterinarian, you cannot get antivenom," said Marais, 65.
Speaking from his headquarters in Pretoria, he casually handled a black mamba during his conversation with AFP.
He said he receives up to a dozen calls a day from desperate animal doctors and dog owners looking for antidotes.
"If your dog gets a serious snakebite today, there's a likelihood it's going to die," Marais said.
Alan Kloeck, of the South African Veterinary Association, confirmed Marais's remarks, describing a "countrywide shortage" with vets unable to get their hands on the antiserum they needed.
- Horse blood, spitting cobras -
South Africa is home to about 160 species of snakes, many of them poisonous.
South African Vaccine Producers -- a NHLS subsidiary and the only antivenom maker in the country -- produces two antidotes.
One can treat bites from 10 snakes including the cape cobra, the puff adder and the green mamba, while another is for relatively rare boomslang bites.
Making the antiserums is a laborious process, said Mike Perry of African Reptiles and Venom, a venom-extraction firm in Centurion, outside Johannesburg, that houses around 900 snakes in small glass cages.
He said his team forces the hissing reptiles to spit out their poison by forcing them to bite a glass jar.
Small quantities of the toxins are then injected into horses, which over time develop immunity.
Their plasma is then harvested and processed to make the serum.
But that process requires constant refrigeration, and the production backlog has been blamed in large part on South Africa's energy crisis, which has caused repeated power blackouts.
In April, NHLS said it required "a consistent and dependable power supply" to produce antivenom.
The continuous switchover to generators during outages interrupted production and affected stockpiles, it said, forcing it to invest in backup power systems and renewable energy.
- 'Last vial' -
Last week, NHLS said it had increased manufacturing in recent months.
Since January, it said, it had delivered antivenom to more than 230 institutions, including hospitals and veterinary clinics, fulfilling all orders apart from "a small backlog" affecting a provincial depot.
But de Kock, whose veterinary practice is in a different province, has not received any shipments since December. For a while, they were using expired doses from other hospitals, but these too have dried up.
"We have used the last vial on Sunday evening," he said last week.
Over the past three months, the hospital treated 25 dogs for snakebites.
Of the 16 who could get expired antivenom, only one did not survive, while six of the nine who could not get doses died.
Zarza was among them, dying in May after a two-day struggle on a ventilator.
"It's tough," said de Kock, 53. "You're doing everything you can but the vital thing that you actually need is the antivenom, and you don't have that".
His hope was that the austral winter months, when snakes are less active, would bring some relief.
S.Gregor--AMWN